Status:
UNKNOWN
Treatment of Plantar Warts
Lead Sponsor:
Sohag University
Conditions:
Plantar Wart
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
This study is to compare the efficacy and safety of topical 30% potassium hydroxide solution and topical 45% hydrogen peroxide solution in treatment of plantar warts.
Eligibility Criteria
Inclusion
- confirmed diagnosis by clinical and dermoscopic examination of plantar warts
Exclusion
- history of hypersensitivity to any component used in this study
- pregnancy and breastfeeding
- patients who receive immune suppressive therapy
- patients who received any wart treatments during the last 2 months before enrollent in the study
- patients who refused participation in the study
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05198180
Start Date
February 1 2022
End Date
December 1 2022
Last Update
January 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag faculty of medicine
Sohag, Egypt